Immune Aging and Immunotherapy in Cancer

Immune functions decline as we age, while the incidence of cancer rises. The advent of immune checkpoint blockade (ICB) has not only revolutionized cancer therapy, but also spawned great interest in identifying predictive biomarkers, since only one third of patients show treatment response. The agin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaiser, Melanie, Semeraro, Maria Donatella, Herrmann, Markus, Absenger, Gudrun, Gerger, Armin, Renner, Wilfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269421/
https://www.ncbi.nlm.nih.gov/pubmed/34209842
http://dx.doi.org/10.3390/ijms22137016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269421/
https://www.ncbi.nlm.nih.gov/pubmed/34209842
http://dx.doi.org/10.3390/ijms22137016

Ejemplares similares